QNTM
Quantum BioPharma Ltd.
There isn't enough reported data to score QNTM yet.
QNTM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
QNTM's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
QNTM PE Valuation
QNTM has no meaningful PE right now: it lost money over the past year.
QNTM Forward outlook
There aren't enough analyst estimates for QNTM to show an outlook.
QNTM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2019 | -$336.79 | -$208.14 |
QNTM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2019 | $180.8K | +32704% |
QNTM's revenue has grown year over year for four quarters in a row: $180,750 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2019 | -14263% | N/A |
| Q4 2018 | -769630% | N/A |
| Q3 2018 | -21824% | N/A |
| Q2 2018 | -11697% | N/A |
QNTM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2019 | -$13.2M | -$11.3M |
| Q4 2018 | -$1.9M | -$1.9M |
| Q3 2018 | $3.1M | +$3.1M |
| Q2 2018 | -$1.6M | -$1.6M |
| Q1 2018 | -$2.4M | -$2.4M |
| Q4 2017 | -$2.6K | -$845 |
| Q3 2017 | -$2.5K | -$1.1K |
QNTM has burned cash in almost every quarter: −$14M over the past year, against −$2M the year before.
QNTM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +4.1K shares |
| 1 year | +7.5% | +7.6K shares |
QNTM has 108,558 diluted shares, up 7.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2018 | — |
| Q3 2018 | — |
| Q2 2018 | — |
| Q1 2018 | — |
| Q4 2017 | — |
| Q3 2017 | — |
| Q2 2017 | — |
| Q1 2017 | — |
QNTM Net Leverage
QNTM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
QNTM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 6.2 | Oversold |
QNTM's weekly RSI is 36 (neutral) and its Stochastic is 6 (oversold).
QNTM PE vs Healthcare Sector
QNTM has no meaningful PE right now: it lost money over the past year.
QNTM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.65 | 33% below |
| 20 week MA | $3.05 | 42% below |
| 50 week MA | $4.41 | 60% below |
| 100 week MA | $8.36 | 79% below |
| 200 week MA | $30.3 | 94% below |
QNTM is in a downtrend: it's below all five of its weekly moving averages, and 94% below its 200-week average.
QNTM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $364.0 | $109.9 | -70% |
| 2021 | $109.9 | $67.0 | -39% |
| 2022 | $67.0 | $50.1 | -25% |
| 2023 | $50.1 | $59.8 | +19% |
| 2024 | $59.8 | $4.06 | -93% |
| 2025 | $4.06 | $8.30 | +104% |
| 2026 YTD | $8.30 | $1.78 | -79% |
QNTM's yearly returns have swung widely, from +104% in 2025 to −93% in 2024. It's down 79% so far in 2026.